Sort

Search

01/08/2024 Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice
Butrón-Bris, B, Llamas-Velasco, M, Ovejero-Benito, MC, Santos-Juanes, J, Martínez-López, A, Ruiz-Villaverde, R, Roustan, G, Baniandrés, O, Izu-Belloso, R, de la Cueva, P, Sahuquillo-Torralba, A, Gónzalez-Quesada, A, Vilarrasa-Rull, E, Pujol-Montcusi, J, García-Martínez, J, Navares, M, Palomar-Moreno, I, Novalbos, J, Abad-Santos, F, Daudén, E, de la Fuente, H. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. EXPERIMENTAL DERMATOLOGY. 2024; 33(8)DOI:10.1111/exd.15152. PMID:39081053. IF:3.100(Q2/3D).
01/08/2024 A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets
Rusinol, L, Puig, L. A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158437. PMID:39126010. IF:4.900(Q1/3D).
01/08/2024 Lentigo maligna: a comprehensive review on diagnosis and treatment
Carmona-Rocha, E, Rusiñol, L, Garcia-Melendo, C, Iznardo, H, Mozos, A, López-Sánchez, C, Yélamos, O. Lentigo maligna: a comprehensive review on diagnosis and treatment. Italian Journal of Dermatology and Venereology. 2024; 159(4)DOI:10.23736/S2784-8671.24.07837-X. PMID:39069838. IF:2.600(Q2/4D).
01/08/2024 Cardiac index-guided therapy to maintain optimised postinduction cardiac index in high-risk patients having major open abdominal surgery: the multicentre randomised iPEGASUS trial
Funcke, S, Schmidt, G, Bergholz, A, Navarro, PA, Cabezón, GA, Barbero-Espinosa, S, Diaz-Cambronero, O, Edinger, F, García-Gregorio, N, Habicher, M, Klinkmann, G, Koch, C, Kröker, A, Mencke, T, García, VM, Zitzmann, A, Lezius, S, Pepic, A, Sessler, DI, Sander, M, Haas, SA, Reuter, DA, Saugel, B. Cardiac index-guided therapy to maintain optimised postinduction cardiac index in high-risk patients having major open abdominal surgery: the multicentre randomised iPEGASUS trial. BRITISH JOURNAL OF ANAESTHESIA. 2024; 133(2)DOI:10.1016/j.bja.2024.03.040. PMID:38797635. IF:9.200(Q1/1D).